Potassium channel blockers inhibit the triggers of attacks in the calcium channel mouse mutant tottering

Journal of Neuroscience

Volumn 25, Issue 16, 2005, Pages 4141-4145

  Weisz, Catherine J C ^a   Raike, Robert S ^a   Soria Jasso, Luis E ^a   Hess, Ellen J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aminopyridine; Caffeine; Calcium channel; Cerebellum; Channelopathy; Dystonia; Potassium; Stress; Tottering mouse

Indexed keywords

3,4 DIAMINOPYRIDINE; 4 AMINOPYRIDINE; AMINOPYRIDINE DERIVATIVE; CAFFEINE; CALCIUM; CALCIUM CHANNEL; POTASSIUM; POTASSIUM CHANNEL BLOCKING AGENT; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CEREBELLUM; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DYSKINESIA; FEMALE; MALE; MOUSE MUTANT; NONHUMAN; PRIORITY JOURNAL;

4-AMINOPYRIDINE; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CAFFEINE; CALCIUM CHANNELS, P-TYPE; CALCIUM CHANNELS, Q-TYPE; CEREBELLUM; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; DYSKINESIAS; MICE; MICE, INBRED C57BL; MICE, NEUROLOGIC MUTANTS; MICROINJECTIONS; MUTATION; POTASSIUM CHANNEL BLOCKERS;

EID: 17644405076     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0098-05.2005     Document Type: Article

References (36)

1. Battistini S, Stenirri S, Piatti M, Gelfi C, Righetti PG, Rocchi R, Giannini F, Battistini N, Guazzi GC, Ferrari M, Carrera P (1999) A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxia. Neurology 53:38-43.
2. Bhatia KP, Griggs RC, Ptacek LJ (2000) Episodic movement disorders as channelopathies. Mov Disord 15:429-433.
3. Campbell DB, Hess EJ (1998) Cerebellar circuitry is activated during convulsive episodes in the tottering (tg/tg) mutant mouse. Neuroscience 85:773-783.
4. 2+ channelopathy. Neuron 43:387-400.
5. Capacio BR, Byers CE, Matthews RL, Chang FC (1996) A method for determining 4-aminopyridine in plasma: pharmacokinetics in anaesthetized guinea pigs after intravenous administration. Biomed Chromatogr 10:111-116.
6. + channels. Ann NY Acad Sci 868:233-285.
7. Denier C, Ducros A, Vahedi K, Joutel A, Thierry P, Ritz A, Castelnovo G, Deonna T, Gerard P, Devoize JL, Gayou A, Perrouty B, Soisson T, Autret A, Warter JM, Vighetto A, Van Bogaert P, Alamowitch S, Roullet E, Tournier-Lasserve E (1999) High prevalence of CACNA1A truncations and broader clinical spectrum in episodic ataxia type 2. Neurology 52:1816-1821.
8. Etzion Y, Grossman Y (2001) Highly 4-aminopyridine sensitive delayed rectifier current modulates the excitability of guinea pig cerebellar Purkinje cells. Exp Brain Res 139:419-425.
9. Fletcher CF, Lutz CM, O'Sullivan TN, Shaughnessy JD, Hawkes R, Frankel WN, Copeland NG, Jenkins NA (1996) Absence epilepsy in tottering mutant mice is associated with calcium channel defects. Cell 87:607-617.
10. Fureman BE, Jinnah HA, Hess EJ (2002) Triggers of paroxysmal dyskinesia in the calcium channel mouse mutant tottering. Pharmacol Biochem Behav 73:631-637.
11. Gordon N (1998) Episodic ataxia and channelopathies. Brain Dev 20:9-13.
12. Griggs RC, Nutt JG (1995) Episodic ataxias as channelopathies. Ann Neurol 37:285-287.
13. Guida S, Trettel F, Pagnutti S, Mantuano E, Tottene A, Veneziano L, Fellin T, Spadaro M, Stauderman K, Williams M, Volsen S, Ophoff R, Frants R, Jodice C, Frontali M, Pietrobon D (2001) Complete loss of P/Q calcium channel activity caused by a CACNA1A missense mutation carried by patients with episodic ataxia type 2. Am J Hum Genet 68:759-764.
14. + currents in rabbit Schwann cells. J Physiol (Lond) 433:183-205.
15. Jen J (1999) Calcium channelopathies in the central nervous system. Curr Opin Neurobiol 9:274-280.
16. Jen J, Wan J, Graves M, Yu H, Mock AF, Coulin CJ, Kim G, Yue Q, Papazian DM, Baloh RW (2001) Loss-of-function EA2 mutations are associated with impaired neuromuscular transmission. Neurology 57:1843-1848.
17. Jinnah HA, Sepkuty JP, Ho T, Yitta S, Drew T, Rothstein JD, Hess EJ (2000) Calcium channel agonists and dystonia in the mouse. Mov Disord 15:542-551.
18. Jouvenceau A, Eunson LH, Spauschus A, Ramesh V, Zuberi SM, Kullmann DM, Hanna MG (2001) Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel. Lancet 358:801-807.
19. Matsumoto M, Riker WK (1984) Effects of several aminopyridines and analogs on the calcium dependence of synaptic transmission. J Pharmacol Exp Ther 228:573-578.
20. Molgo J, Lemeignan M, Lechat P, Peradejordi F (1985) Increase in evoked transmitter release from motor nerve terminals by some amino N-heterocyclic compounds I. Comparative experimental activities and extracellular pH-dependence. Eur J Med Chem 20:149-153.
21. 2+ channel gene CACNL1A4. Cell 87:543-652.
22. Peradejordi F, Molgo J, Lemeignan M (1985) Increase in evoked transmitter release from motor nerve terminals by some amino N-heterocyclic compounds II. Comparative study on electronic structural properties and reactivity characteristics of neutral and protonated molecular species. The interaction pharmacophore. Eur J Med Chem 20:155-161.
23. Ptacek LJ (1997) Channelopathies: ion channel disorders of muscle as a paradigm for paroxysmal disorders of the nervous system. Neuromuscul Disord 7:250-255.
24. Ptacek LJ, George ALJ, Griggs RC, Tawil R, Kallen RG, Barchi RL, Robertson M, Leppert MF (1991) Identification of a mutation in the gene causing hyperkalemic periodic paralysis. Cell 67:1021-1027.
25. Ptacek LJ, George ALJ, Barchi RL, Griggs RC, Riggs JE, Robertson M, Leppert MF (1992) Mutations in an S4 segment of the adult skeletal muscle sodium channel cause paramyotonia congenita. Neuron 8:891-897.
26. Ptacek LJ, Tawil R, Griggs RC, Engel AG, Layzer RB, Kwiecinski H, McManis PG, Santiago L, Moore M, Fouad G, Bradley P, Leppert MF (1994) Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell 77:863-868.
27. Spacey SD, Hildebrand ME, Materek LA, Bird TD, Snutch TP (2004) Functional implications of a novel EA2 mutation in the P/Q-type calcium channel. Ann Neurol 56:213-220.
28. Stea A, Tomlinson WJ, Soong TW, Bourinet E, Dubel SJ, Vincent SR, Snutch TP (1994) Localization and functional properties of a rat brain α 1A calcium channel reflect similarities to neuronal Q- and P-type channels. Proc Natl Acad Sci USA 91:10576-10580.
29. Strupp M, Schuler O, Krafczyk S, Jahn K, Schautzer F, Buttner U, Brandt T (2003) Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study. Neurology 61:165-170.
30. Strupp M, Kalla R, Dichgans M, Freilinger T, Glasauer S, Brandt T (2004) Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine. Neurology 62:1623-1625.
31. Subramony SH, Schott K, Raike RS, Callahan J, Langford LR, Christova PS, Anderson JH, Gomez CM (2003) Novel CACATA1A mutation causes febrile episodic ataxia with interictal cerebellar deficits. Ann Neurol 54:725-731.
32. 2--channels: four subtypes of α1 and β-subunits in developing and mature rat brain. Brain Res Mol Brain Res 30:1-16.
33. Volsen SG, Day FC, McCormack AL, Smith W, Craig PJ, Beattie R, Ince PG, Shaw PJ, Ellis SB, Gillespie A, Harpold MM, Lodge D (1995) The expression of neuronal voltage-dependent calcium channels in human cerebellum. Brain Res Mol Brain Res 34:271-282.
34. Wakamori M, Yamazaki K, Matsunodaira H (1998) Single tottering mutations responsible for the neuropathic phenotype of the P-type calcium channel. J Biol Chem 52:34857-34867.
35. v2.1 missense mutations associated with episodic ataxia type 2 and progressive ataxia. J Biol Chem 277:6960-6966.
36. Womack MD, Khodakhah K (2004) Dendritic control of spontaneous bursting in cerebellar Purkinje cells. J Neurosci 24:3511-3521.